- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01894880
Pilot Study: Sectio Bonding/Early Skin-to-skin Contact (SSC) After Caesarean Section (SSC)
In the past decades frequency of cesarean section was increasing. Bonding or early skin-to-skin contact (SSC) starts ideally straight after birth. After vaginal delivery bonding/early SSC is already well-established. After cesarean section this important process starts after termination of operation. A Cochran review analyzed randomized studies and shows positive effects of early SSC. Possible concerns to adopt bonding in the operating room are beside organizational ones (change of established processes) also a different ambiance in the operating room (temperature, light, noise). In a prospective randomized trial, early SSC after cesarean section should be analyzed.
Hypothesis
Mothers, who have the chance to bond immediately after birth in the operating room, have lower cortisol, chromogranin A and alpha amylase levels as well as higher oxytocin levels. Adaptation of the newborn is within the normal range. Early bonding has a further positive effect on breast feeding, maternal pain processing and mental health.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Graz, Austria, 8036
- Medical University of Graz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age > 18 years
- signed written informed consent
- single pregnancy
- elective cesarean section (between 7am and 15pm)
- Bleeding prophylaxis with Pabal® (carbetocin)
Exclusion Criteria:
- Age < 18 years
- disabled to give signed written informed consent
- Disease of mother or unborn, which could influence the study or makes the study impossible (e.g. severe malformation)
- Non elective cesarean
- Desire to wean
- Desire to leave the hospital within 6 hours after birth
- Bleeding prophylaxis with Syntocinon® (oxytocin)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: early SSC
Early SSC: bonding straight after birth
|
bonding straight after birth
|
Other: late SSC
late SSC: bonding after termination of operation
|
bonding after termination of operation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change of oxytocin level
Time Frame: before, 0 min and 25 minutes after birth
|
before, 0 min and 25 minutes after birth
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change of cortisol level
Time Frame: before, 0 min and 25 min after birth
|
before, 0 min and 25 min after birth
|
Change of alpha Amylase level
Time Frame: before, 0 min and 25 min after birth
|
before, 0 min and 25 min after birth
|
Change of chromogranin A level
Time Frame: before, 0 min and 25 min after birth
|
before, 0 min and 25 min after birth
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change of pain scores on the Visual Analog Scale (VAS)
Time Frame: day 1 and 2 after birth
|
day 1 and 2 after birth
|
Post natal Depression (edinburgh post natal Depression scale)
Time Frame: day 4 after birth
|
day 4 after birth
|
Post natal Depression (edinburgh post natal Depression scale)
Time Frame: 6 weeks after birth
|
6 weeks after birth
|
Bonding behaviour (Postpartum Bonding Questionnaire )
Time Frame: day 4 after birth
|
day 4 after birth
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Martina Kollmann, MD, Medical University of Graz
- Study Chair: Philipp Klaritsch, MD, Medical University of Graz
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 25-425ex12/13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Early Skin-to-skin Contact
-
Rachel BakerCompleted
-
Turku University HospitalNot yet recruitingParenting | Psychological Distress | Preterm Infant | Early Skin-to-skin Contact
-
Herlev and Gentofte HospitalKarolinska InstitutetCompleted
-
Herlev and Gentofte HospitalGöteborg University; University of Copenhagen; Sahlgrenska University Hospital...CompletedAllergic Contact Dermatitis Due to CosmeticsDenmark, Sweden
-
Wake Forest University Health SciencesCompletedSkin to Skin Contact in Cesarean DeliveriesUnited States
-
University Ghent3MTerminatedPressure Ulcer | Diaper Rash | Incontinence-associated Dermatitis | Irritant Contact Dermatitis Due to IncontinenceBelgium
-
Mersin UniversityCompleted
-
University of AarhusCompletedPhysiological Responses to Contact With Dogs | Psychological Responses to Contact With Dogs | Behavioural Responses to Contact With DogsDenmark
-
National Allergy Research Center, DenmarkNational Research Centre for the Working Environment, Denmark; Bispebjerg Hospital and other collaboratorsCompleted
-
Hospices Civils de LyonRecruitingContact Dermatitis | Contact Dermatitis Irritant | Contact Dermatitis, AllergicFrance
Clinical Trials on early SSC
-
Medical University of GrazRecruitingPreterm Birth | Ventilator Lung; NewbornAustria
-
Kaleido BiosciencesCompletedMild-to-Moderate COVID-19United States
-
Kaleido BiosciencesCompletedMild-to-moderate COVID-19United States
-
University Hospital, ToursNot yet recruitingPremature Newborns | Skin to SkinFrance
-
St. Justine's HospitalRecruitingNeurodevelopmental DisordersCanada
-
Inovio PharmaceuticalsCoalition for Epidemic Preparedness InnovationsCompleted
-
Antalya Training and Research HospitalCompletedFibromyalgia | Systemic SclerosisTurkey
-
Stony Brook UniversityCompletedMental Health ImpairmentUnited States
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Rouen; University Hospital, Caen; University Hospital, Lille and other collaboratorsRecruitingPreterm Infant | Body TemperatureFrance
-
Hospices Civils de LyonUnknownLung Diseases, Interstitial | Lung Disease With Systemic SclerosisFrance